Cayuga Biotech

📍 New York and Massachusetts, United States👥 9 employees💰 Last funded Apr 2025
Biotechnology🌐 cayugabiotech.com
Website LinkedIn
Cayuga is developing novel biomimetic therapies leveraging inorganic polyphosphate, a polymer that modulates the healing response. The company has an optimized polyP-SNP complex in late preclinical development for the treatment of acute major hemorrhage, a discovery-stage novel composition for the treatment of inherited bleeding disorders, as well as a portfolio of early-stage programs focused across the healing continuum. To learn more, please visit www.CayugaBiotech.com.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Cayuga Biotech?
Cayuga Biotech has 1 investors on record on gritt.io.
When did Cayuga Biotech last raise funding?
The most recent investment in Cayuga Biotech recorded on gritt.io was in April 2025.
What industry is Cayuga Biotech in?
Cayuga Biotech operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Cayuga Biotech based?
Cayuga Biotech is headquartered in New York and Massachusetts, United States.